# OnCo record nct04969731 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04969731/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04969731", "NCT04969731" ;
  schema:name "Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer"@en ;
  schema:description "A phase 3 trial of Gemcitabine in pancreatic ductal adenocarcinoma, run by GC Cell Corporation, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04969731/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04969731> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-09-07" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/gc-cell/> .